Elanco Animal Health (ELAN) Cash from Investing Activities (2017 - 2026)
Elanco Animal Health's Cash from Investing Activities history spans 9 years, with the latest figure at -$64.0 million for Q4 2025.
- On a quarterly basis, Cash from Investing Activities rose 28.89% to -$64.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$279.0 million, a 124.09% decrease, with the full-year FY2025 number at -$279.0 million, down 124.09% from a year prior.
- Cash from Investing Activities hit -$64.0 million in Q4 2025 for Elanco Animal Health, up from -$101.0 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for ELAN hit a ceiling of $1.2 billion in Q3 2024 and a floor of -$441.0 million in Q3 2021.
- Historically, Cash from Investing Activities has averaged $50000.0 across 5 years, with a median of -$40.0 million in 2022.
- Biggest five-year swings in Cash from Investing Activities: tumbled 390.0% in 2022 and later surged 3555.56% in 2024.
- Tracing ELAN's Cash from Investing Activities over 5 years: stood at -$74.0 million in 2021, then fell by 2.7% to -$76.0 million in 2022, then surged by 53.95% to -$35.0 million in 2023, then tumbled by 157.14% to -$90.0 million in 2024, then grew by 28.89% to -$64.0 million in 2025.
- Business Quant data shows Cash from Investing Activities for ELAN at -$64.0 million in Q4 2025, -$101.0 million in Q3 2025, and -$56.0 million in Q2 2025.